Compare FSBC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSBC | MPLT |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.4M | 811.3M |
| IPO Year | 2021 | N/A |
| Metric | FSBC | MPLT |
|---|---|---|
| Price | $41.45 | $30.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $40.75 | $32.67 |
| AVG Volume (30 Days) | 73.9K | ★ 307.6K |
| Earning Date | 04-27-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 28.32 | N/A |
| EPS | ★ 2.90 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.25 | N/A |
| Revenue Next Year | $12.30 | N/A |
| P/E Ratio | $14.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.26 | $12.24 |
| 52 Week High | $42.26 | $33.28 |
| Indicator | FSBC | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 64.77 |
| Support Level | $35.58 | $15.34 |
| Resistance Level | $40.79 | N/A |
| Average True Range (ATR) | 1.11 | 2.87 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 49.09 | 72.03 |
Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.